ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Allergic Rhinitis
Pulmonary Eosinophilia
Rhinitis
Chronic Obstructive Pulmonary Disease
Dust Mite Allergy
Lung Diseases
Respiratory Tract Diseases

Asthma trials near Kansas City, KS, USA:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Kansas City, Missouri, United States and 115 other locations

This is a Phase 2, randomized, multicenter study in adult and adolescent participants with asthma and type 2 inflammation...

Enrolling
Asthma Acute
Combination Product: Rademikibart in prefilled syringe
Drug: Matching placebo in prefilled syringe

Phase 2

Connect Biopharm LLC

Kansas City, Kansas, United States and 48 other locations

This is a study to determine the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of CDX-622 in adults with mild to moderate asthma....

Enrolling
Mild to Moderate Asthma
Drug: CDX-622

Phase 1

Celldex Therapeutics
Celldex Therapeutics

Kansas City, Kansas, United States and 1 other location

immunogenicity of APG777 in adult participants with mild-to-moderate asthma.The duration of the study will be approximately 52 weeks (364 da...

Active, not recruiting
Asthma
Drug: Placebo
Drug: APG777

Phase 1

Apogee Therapeutics, Inc.

Kansas City, Missouri, United States and 12 other locations

PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...

Enrolling
Asthma
Other: Placebo
Drug: PF-07275315

Phase 2

Pfizer
Pfizer

Kansas City, Kansas, United States and 124 other locations

Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) Over a 12-Week Treatment Period in Patients With Severe Asthma...

Begins enrollment in 1 month
Severe Asthma
Drug: Placebo
Drug: Frevecitinib

Phase 2

Kinaset Therapeutics

Kansas City, Missouri, United States and 14 other locations

Locations recently updated

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...

Enrolling
Asthma
Drug: dupilumab
Drug: Matching Placebo

Phase 4

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Kansas City, Kansas, United States and 83 other locations

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...

Enrolling
Asthma
Drug: Budesonide/Albuterol
Drug: Lunsekimig

Phase 2

Sanofi
Sanofi

Westwood, Kansas, United States and 244 other locations

inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...

Enrolling
Asthma
Drug: Albuterol sulfate
Drug: TEV-56248

Phase 3

Teva Branded Pharmaceutical Products R&D LLC

Kansas City, Missouri, United States and 393 other locations

MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis...

Enrolling
Asthma
Combination Product: BDA MDI
Combination Product: AS MDI

Phase 3

AstraZeneca
AstraZeneca

Kansas City, Kansas, United States and 128 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems